Login

Healthcare

00:10:00
Chief Technology Officer Michael Tolentino, MD, is with Aviceda Therapeutics. | Mohamed Genead, MD, CHIEF EXECUTIVE OFFICER, AVICEDA THERAPEUTICS INC
00:10:00
Alimera Sciences is a pioneering presence in the realm of ophthalmology | RICK EISWIRTH, PRESIDENT AND CHIEF EXECUTIVE OFFICER, ALIMERA SCIENCES INC
00:10:00
Day 4 of the 2024 Mining Indaba: Keamogetswe Mpofu's Mechanical Engineering PIT | DR. NOMBASA TSENGWA ,CHIEF EXECUTIVE OFFICER (MEMBER SOCIAL, ETHICS AND RESPONSIBILITY COMMITTEE), EXXARO RESOURCES LTD
00:10:00
Q&A with Carbios Chief Executive Officer Emmanuel Ladent | EMMANUEL LADENT, CHIEF EXECUTIVE OFFICER, CARBIOS
00:10:00
Mad Money: Aurinia Pharmaceuticals CEO: Speculative Salvation? | Peter Greenleaf, CEO, AURINIA PHARMACEUTICALS INC
00:00:00
AirXpanders Inc.(ASX:AXP) sales and product update - Scott Dodson, CEO,AirXpanders Inc
00:00:00
Dr. Tim Rodell, M.D., CEO and Director at Aethlon Medical, Inc
00:00:00
Company Overview: Aeterna Zentaris Inc. - David Dodd, CEO, Aeterna Zentaris Inc.
00:00:00
Advanced Oncotherapy present research potentially offering 'powerful weapon to resistant cancers' - Jonathan Farr, Chief Clinical Officer, Advanced Oncotherapy
00:00:00
Advanced Oncotherapy now has the ammo to "democratise proton therapy", says CEO - Nicolas Serandou, CEO, Advanced Oncotherapy
00:00:00
Advanced Oncotherapy PLC on its proton beam therapy system - Dr Johnathan Farr , chief clinical officer at Advanced Oncotherapy
00:00:00
Admedus (ASX:AHZ) CEO Wayne Paterson podcast
00:00:00
Admedus (ASX:AHZ) CEO Wayne Paterson interview
00:00:00
Admedus Ltd proud to unveil its valves publicly for the first time in London - Wayne Paterson, CEO, Admedus Ltd
00:00:00
Admedus Ltd 'in good shape' with minimal disruption to supply chain as it advances SAVR trial - Wayne Paterson, CEO, Admedus Ltd
00:00:00
Addex Therapeutics CEO Tim Dyer: There is a $4-bil market opportunity in dyskinesia

© 2026 Nehu